Table 2.
Tumor type | No. of cases | HIF-1α and HIF-2α positive | HIF-1α-positive only | HIF-2α-positive only | HIF-1α and HIF-2α negative |
---|---|---|---|---|---|
Bladder adenocarcinoma | 5 | 2 | 0 | 0 | 3 |
Glioblastoma multiforme | 5 | 2 | 0 | 0 | 3 |
Breast adenocarcinoma | 12 | 10 | 0 | 1 | 1 |
Colon adenocarcinoma | 5 | 4 | 0 | 0 | 1 |
Hepatocellular carcinoma | 5 | 2 | 0 | 0 | 3 |
Hypernephroma | 5 | 2 | 2 | 0 | 1 |
Lung tumors (squamous cell, adenocarcinoma) | 5 | 0 | 0 | 0 | 5 |
Ovarian adenocarcinoma | 5 | 5 | 0 | 0 | 0 |
Pancreatic adenocarcinoma | 3 | 2 | 0 | 1 | 0 |
Prostatic adenocarcinoma | 5 | 2 | 0 | 1 | 2 |
Buffy coat chronic myeloid leukemia | 2 | 0 | 0 | 0 | 2 |
Totals | 57 | 31 | 2 | 3 | 21 |
In addition, HIF-2α expression was detected within subsets of tumor-associated macrophages in all cases.